BIO
Jenny Denney
Executive Vice President and Global Head of FSP
Jenny Denney is Executive Vice President and Global Head of FSP Clinical and Biometrics. In this role, she provides leadership and strategic direction to Parexel’s Clinical and Biometrics business leading diverse functional teams of over 3,000 employees worldwide.
Jenny is a seasoned biopharmaceutical executive with over 25 years of experience in clinical research and development, commercial strategy, and senior leadership working with CROs, large pharma, and biotech across all delivery models.
As Senior Vice President and head of Strategic Clinical Leadership of Global Clinical Operations (GCO) at Parexel, she led the clinical strategy and oversight for the company’s top partnership accounts. This included developing the infrastructure to manage the complex transition of work from Full Service to FSP for top global pharmaceutical companies. During her career, Jenny has been involved with multiple NDA submissions and regulatory authority inspections.
She is a key member of the Drug Information Association (DIA) Regional Advisory Council providing expert consultation and insight into the healthcare ecosystem across political, economic, social, technological, environmental, and legal factors to develop a future looking landscape.
Jenny has an MBA with a concentration in biopharmaceutical management and a PMP certification. Her undergraduate degrees are in biochemistry, chemistry, and genetics. She serves on the Board of Directors for the Museum of Life and Science in North Carolina connecting her passion for the sciences to philanthropy work to inspire the next generation of scientists. She is based near Parexel’s corporate headquarters in Durham, NC.